Onkos Surgical has opened the NanoCept Innovation Center in Bridgewater, aiming to advance its antibacterial coating technology for orthopaedic implants. The company’s founder and CEO, Patrick Treacy, said, “Onkos is proud to have worked with the FDA to bring to market the first antibacterial coating technology. The opening of the NanoCept Innovation Center marks another important milestone in our company’s journey.”
Treacy added, “This investment will allow us to get this groundbreaking technology into the hands of more surgeons, faster, and it puts us in a position to help more patients with complex orthopaedic conditions.”
The new facility will employ chemists, engineers, and technicians focused on innovation operations. Onkos Surgical’s headquarters are located at 77 East Halsey Road in Parsippany.
Steven Gitelis, MD, Director of Rush University/MD Anderson’s Orthopaedic Oncology Program and Chief Medical Officer of Onkos, commented on the significance of the technology: “I am excited by Onkos’ commitment to bring this technology to more implants and ultimately to more patients.” He also stated, “This is a unique technology that arms us, as surgeons, with a powerful solution to help mitigate the serious issue of bacteria in the operating room.”
The ribbon-cutting ceremony for the center took place on December 9. Attendees included NJBIA Vice President of Government Affairs Althea D. Ford; Bridgewater Township Councilman Michael Kirsh; Erin D’Auria, District Director for Congressman Tom Kean Jr.; John Coelho from New Jersey Economic Development Authority; and Jessica Paolini from Somerset County Economic Development.
